John Hendrickson - Perrigo Company President

<div class='logoBackup' style='background:#0D8ECF;color: white;font-size:3em;;'>PRG</div>
PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  President
Mr. John T. Hendrickson is no longer President, Chief Executive Officer and Director at Perrigo Company Public Limited Company effective January 15, 2018. He held these three roles since June 13, 2016. His work experience includes the following roles President at the Company, Executive Vice President Global Operations and Supply Chain at the Company, Executive Vice President and General Manager of Perrigo Consumer Healthcare, Executive Vice President of Operations at the Company, Research and Development Group Leader at Procter Gamble and RD Engineer . He holds a BS degree in Chemistry from Hope College, a BS degree in Chemical Engineering from University of Michigan and a MBA degree from University of Notre Dame.
Age: 53  President Since 2016  MBA    
353 1 709 4000  http://www.perrigo.com

John Hendrickson Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 2.19 % which means that it generated profit of $2.19 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 4.32 % meaning that it created $4.32 on every $100 dollars invested by stockholders.
The company currently holds 3.5 B in liabilities with Debt to Equity (D/E) ratio of 60.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 2.03 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Ganadhish KamatDr Reddys Laboratories Ltd
2016
Sripada ChandrasekharDr Reddys Laboratories Ltd
2013
Saumen ChakrabortyDr Reddys Laboratories Ltd
2018
Clinton LewisZoetis
2018
George YancopoulosRegeneron Pharmaceuticals
2016
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Michael PariniVertex Pharmaceuticals Incorpor
2017
Kimberly WhiteVertex Pharmaceuticals Incorpor
2018
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Joseph LaRosaRegeneron Pharmaceuticals
2019
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
Douglas McCorkleRegeneron Pharmaceuticals
2007
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Raghav ChariDr Reddys Laboratories Ltd
2013
Amit BiswasDr Reddys Laboratories Ltd
2016
John GrayVertex Pharmaceuticals Incorpor
2019
Marion McCourtRegeneron Pharmaceuticals
2018
Roman TrawickiZoetis
2015
Alok SonigDr Reddys Laboratories Ltd
2015
J RamachandranDr Reddys Laboratories Ltd
2016

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug ManufacturersSpecialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Current Sentiment - PRGO

Perrigo Company Investor Sentiment

Most of Macroaxis users are at this time bullish on Perrigo Company Plc. What is your perspective on investing in Perrigo Company Plc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

SSM   
Sold over 100K shares of
3 days ago
Traded for 0.175
S32   
Purchased over 10K shares of
3 days ago
Traded for 2.5
BSL   
Purchased over 100 shares of
3 days ago
Traded for 15.49
MBI   
Purchased over 100 shares of
3 days ago
Traded for 9.2
MDLZ   
Purchased over 100 shares of
3 days ago
Traded for 54.19
Please also check Your Equity Center. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.